RESULTS FROM TWO PHASE 3 RANDOMIZED TRIALS OF ENOBOSARM, SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM), FOR THE PREVENTION AND TREATMENT OF MUSCLE WASTING IN NSCLC.

被引：0
|
作者：
Crawford, Jeffrey [1 ]
Prado, Carla M. M. [2 ]
Hancock, Michael L. [3 ]
Johnston, Mary A. [3 ]
Dalton, James T. [3 ]
Steiner, Mitchell S. [3 ]
机构：
[1] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[2] Florida State Univ, Tallahassee, FL 32306 USA
[3] Gtx Inc, Memphis, TN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
muscle wasting; cachexia; NSCLC; enobosarm;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-026
引用
收藏
页码：S1199 / S1199
页数：1
相关论文
共 50 条
  • [41] Guselkumab Improves Anemia in Patients with Active Psoriatic Arthritis: Results From Two Phase 3 Randomized Controlled Clinical Trials
    Kavanaugh, Arthur
    Liu, Yang
    Rahman, Proton
    Mease, Philip
    Gossec, Laure
    Xu, Lillian
    Hsia, Elizabeth
    Shawi, May
    Han, Chenglong
    Neuhold, Marlies
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 788 - 789
  • [42] Secukinumab Improves Physical Function in Subjects With Plaque Psoriasis and Psoriatic Arthritis: Results from Two Randomized, Phase 3 Trials
    Gottlieb, Alice B.
    Langley, Richard G.
    Philipp, Sandra
    Sigurgeirsson, Bardur
    Blauvelt, Andrew
    Martin, Ruvie
    Papavassilis, Charis
    Mpofu, Shephard
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (08) : 821 - 833
  • [43] Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2)
    Simpson, E. L.
    Bieber, T.
    Guttman-Yassky, E.
    Beck, L. A.
    Blauvelt, A.
    Cork, M. J.
    Silverberg, J. I.
    Deleuran, M.
    Kataoka, Y.
    Lacour, J. -P.
    Kingo, K.
    Worm, M.
    Poulin, Y.
    Wollenberg, A.
    Soo, Y.
    Graham, N. M. H.
    Pirozzi, G.
    Akinlade, B.
    Staudinger, H.
    Mastey, V.
    Eckert, L.
    Gadkari, A.
    Ardeleanu, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 79 - 79
  • [44] Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
    Hayden, Frederick G.
    Lenk, Robert P.
    Stonis, Lucille
    Oldham-Creamer, Catherine
    Kang, Lih Lisa
    Epstein, Carol
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1790 - 1799
  • [45] Improvements in Patient-Reported Outcomes After Treatment with SEL-212 in Adults with Refractory Gout: Results from Two Randomized Phase 3 Trials
    Strand, Vibeke
    Khanna, Puja
    Kivitz, Alan
    Kragh, Nana
    Falk, Aletta
    Azeem, Rehan
    Santin-Janin, Hugues
    Baraf, Herbert
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 700 - 703
  • [46] TREATMENT OF HYPERKALEMIA WITH ZS-9, A SELECTIVE NONABSORBED CATION EXCHANGE RESIN, DOES NOT LEAD TO HYPOMAGNESEMIA: RESULTS FROM TWO MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 3 TRIALS
    El-Shahawy, Mohamed A.
    Rasmussen, Henrik S.
    Lavin, Philip T.
    Yang, Alex
    Qunibi, Wajeh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A842 - A842
  • [47] Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials
    Lipton, Richard B.
    Blumenfeld, Andrew
    Jensen, Christopher M.
    Croop, Robert
    Thiry, Alexandra
    L'Italien, Gilbert
    Morris, Beth A.
    Coric, Vladimir
    Goadsby, Peter J.
    CEPHALALGIA, 2023, 43 (02)
  • [48] Alefacept treatment results in clinically meaningful improvement in patients with chronic plaque psoriasis: Results from two randomized, placebo-controlled phase III trials
    Balkrishnan, R
    Feldman, SR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (06) : 1569 - 1569
  • [49] MRI ANALYSIS FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS; TREATMENT OF SYMPTOMATIC KNEE OSTEOARTHRITIS WITH ORAL SALMON CALCITONIN
    Karsdal, M. A.
    Dam, E. B.
    Byrjalsen, I.
    Bihlet, A.
    Andersen, J. R.
    Riis, B. J.
    Alexandersen, P.
    Bay-Jensen, A. -C.
    Christiansen, C.
    OSTEOARTHRITIS AND CARTILAGE, 2015, 23 : A394 - A395
  • [50] Clinical Profile of the Novel Oral CGRP Receptor Antagonist Telcagepant for the Acute Treatment of Migraine in Two Phase 3 Randomized Placebo Controlled Trials
    Ho, Tony W.
    Ferrari, Michel D.
    Dodick, David W.
    Shapiro, Robert E.
    Diener, Hans-Christopher
    Lucas, Sylvia
    Galet, Vince
    Kost, James
    Fan, Xiaoyin
    Leibensperger, Heather
    Froman, Samar
    Fei, Kaiyin
    Assaid, Christopher
    Lines, Christopher
    Koppen, Hille
    Winner, Paul
    Connor, Kathryn M.
    NEUROLOGY, 2009, 72 (11) : A250 - A250
12345